VAERS reports by lot

GSK Varicella/Shingles lot 99D9F: VAERS reports

33 VAERS reports list lot 99D9F as a GSK Varicella/Shingles vaccine, received between 2019-04-17 and 2021-05-13. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
33
Reports
12%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2624%
General / Systemic (non-local)2523%
Musculoskeletal2119%
Neurological1413%
Dermatological (non-injection-site)66%
Allergic / Anaphylactic55%
Respiratory44%
Gastrointestinal33%
Cardiac / Cardiovascular22%
Autoimmune / Immune-mediated11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Maine4
New York3
South Carolina3
West Virginia3
Ohio3
California3
Michigan2
Minnesota2
Massachusetts2
North Carolina1
Oregon1
New Jersey1

Reports by month received

2019-046
2019-059
2019-067
2019-073
2019-083
2019-091
2019-101
2019-111
2019-121
2021-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.